{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T17:53:35Z","timestamp":1788285215779,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T00:00:00Z","timestamp":1596758400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T00:00:00Z","timestamp":1596758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The apolipoprotein E (APOE) e4 allele is the most common genetic variant associated with Alzheimer\u2019s disease (AD). We sought to investigate the distribution of APOE genotypes across the full clinical AD spectrum including AD, late-stage amnestic mild cognitive impairment (L-aMCI), early-stage aMCI (E-aMCI), subjective memory impairment (SMI), and controls. We prospectively recruited 713 AD patients, 735 aMCI patients, 575 SMI patients, and 8,260 individuals as controls. The frequency of the APOE e4 allele revealed an ordered fashion in the AD (30.8%), L-aMCI (24.0%), E-aMCI (15.1%), SMI (11.7%), and control (9.1%) groups. APOE e3\/e4 and e4\/e4 genotype frequencies also appeared in an ordered fashion in the AD group (39.1% of e3\/e4 and 10.9% of e4\/e4), as well as the L-aMCI (28.3% and 9.4%), E-aMCI (22.3% and 3.7%), SMI (18.3% and 1.9%), and control (15.1% and 0.8%) groups. In the comparisons of APOE e3\/e3 vs. e3\/e4 genotypes, all patient groups had a higher frequency of APOE e3\/e4 relative to the control group. Relative to the SMI and E-aMCI groups, the AD and L-aMCI groups had higher frequency of the APOE e3\/e4 genotype, and the AD group had a higher frequency relative to the L-aMCI group. However, there was no significant difference between the E-aMCI and SMI groups. In our longitudinal data, APOE e4 carrier showed a steeper incline slope in a clinical dementia rating sum of boxes (CDR-SB) score than APOE e4 non-carrier in SMI (B\u2009=\u20090.0066, p\u2009=\u20090.0104), E-aMCI (B\u2009=\u20090.0313, p\u2009&lt;\u20090.0001), and L-aMCI (B\u2009=\u20090.0178, p\u2009=\u20090.0007). APOE e4 carrier showed a steeper decline slope in the CDR-SB than APOE e4 non-carrier in AD (B\u2009=\u2009\u2212 0.0309, p\u2009=\u20090.0003). These findings suggest that E-aMCI and SMI are associated with a similarly increased frequency of the APOE e4 allele compared to controls, suggesting a greater genetic risk for AD and the importance of monitoring the allele more closely.<\/jats:p>","DOI":"10.1038\/s41598-020-69603-w","type":"journal-article","created":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T10:03:50Z","timestamp":1596794630000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Distribution and clinical impact of apolipoprotein E4 in subjective memory impairment and\u00a0early mild cognitive impairment"],"prefix":"10.1038","volume":"10","author":[{"given":"Hanna","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4082-7630","authenticated-orcid":false,"given":"Young-Eun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wonjeong","family":"Chae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ko Woon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duk L.","family":"Na","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Seok","family":"Ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Won","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,7]]},"reference":[{"key":"69603_CR1","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder, E. H. et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science261, 921\u2013923 (1993).","journal-title":"Science"},{"key":"69603_CR2","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.neuron.2010.10.013","volume":"68","author":"L Bertram","year":"2010","unstructured":"Bertram, L., Lill, C. M. & Tanzi, R. E. The genetics of Alzheimer disease: Back to the future. Neuron68, 270\u2013281 (2010).","journal-title":"Neuron"},{"key":"69603_CR3","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","volume":"90","author":"WJ Strittmatter","year":"1993","unstructured":"Strittmatter, W. J. et al. Apolipoprotein E: High-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA90, 1977\u20131981 (1993).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"69603_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0361-9230(03)00067-4","volume":"61","author":"A Rocchi","year":"2003","unstructured":"Rocchi, A., Pellegrini, S., Siciliano, G. & Murri, L. Causative and susceptibility genes for Alzheimer\u2019s disease: A review. Brain Res. Bull.61, 1\u201324 (2003).","journal-title":"Brain Res. Bull."},{"key":"69603_CR5","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1159\/000124750","volume":"25","author":"WM van der Flier","year":"2008","unstructured":"van der Flier, W. M. et al. Distribution of APOE genotypes in a memory clinic cohort. Dement. Geriatr. Cogn. Disord.25, 433\u2013438 (2008).","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"69603_CR6","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jalz.2012.09.017","volume":"10","author":"F Jessen","year":"2014","unstructured":"Jessen, F. et al. AD dementia risk in late MCI, in early MCI, and in subjective memory impairment. Alzheimers Dement.10, 76\u201383 (2014).","journal-title":"Alzheimers Dement."},{"key":"69603_CR7","doi-asserted-by":"crossref","first-page":"e99130","DOI":"10.1371\/journal.pone.0099130","volume":"9","author":"X Wang","year":"2014","unstructured":"Wang, X., Wang, H., Li, H., Li, T. & Yu, X. Frequency of the apolipoprotein E epsilon4 allele in a memory clinic cohort in Beijing: A naturalistic descriptive study. PLoS\u00a0One9, e99130 (2014).","journal-title":"PLoS\u00a0One"},{"key":"69603_CR8","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jalz.2010.03.006","volume":"6","author":"PS Aisen","year":"2010","unstructured":"Aisen, P. S. et al. Clinical core of the Alzheimer\u2019s disease neuroimaging initiative: Progress and plans. Alzheimers Dement.6, 239\u2013246 (2010).","journal-title":"Alzheimers Dement."},{"key":"69603_CR9","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/YCO.0b013e3283586fd8","volume":"25","author":"R Stewart","year":"2012","unstructured":"Stewart, R. Subjective cognitive impairment. Curr. Opin. Psychiatry25, 445\u2013450 (2012).","journal-title":"Curr. Opin. Psychiatry"},{"key":"69603_CR10","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/1099-1166(200011)15:11<983::AID-GPS238>3.0.CO;2-5","volume":"15","author":"C Jonker","year":"2000","unstructured":"Jonker, C., Geerlings, M. I. & Schmand, B. Are memory complaints predictive for dementia? A review of clinical and population-based studies. Int. J. Geriatr. Psychiatry15, 983\u2013991 (2000).","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"69603_CR11","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1176\/ajp.156.4.531","volume":"156","author":"MI Geerlings","year":"1999","unstructured":"Geerlings, M. I., Jonker, C., Bouter, L. M., Ader, H. J. & Schmand, B. Association between memory complaints and incident Alzheimer\u2019s disease in elderly people with normal baseline cognition. Am. J. Psychiatry156, 531\u2013537 (1999).","journal-title":"Am. J. Psychiatry"},{"key":"69603_CR12","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1001\/archgenpsychiatry.2010.30","volume":"67","author":"F Jessen","year":"2010","unstructured":"Jessen, F. et al. Prediction of dementia by subjective memory impairment: Effects of severity and temporal association with cognitive impairment. Arch. Gen. Psychiatry67, 414\u2013422 (2010).","journal-title":"Arch. Gen. Psychiatry"},{"key":"69603_CR13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jalz.2009.10.002","volume":"6","author":"B Reisberg","year":"2010","unstructured":"Reisberg, B., Shulman, M. B., Torossian, C., Leng, L. & Zhu, W. Outcome over seven years of healthy adults with and without subjective cognitive impairment. Alzheimers Dement.6, 11\u201324 (2010).","journal-title":"Alzheimers Dement."},{"key":"69603_CR14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3389\/fnagi.2013.00011","volume":"5","author":"SL Risacher","year":"2013","unstructured":"Risacher, S. L. et al. The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI). Front. Aging Neurosci.5, 11 (2013).","journal-title":"Front. Aging Neurosci."},{"key":"69603_CR15","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jalz.2013.05.1764","volume":"10","author":"J Peter","year":"2014","unstructured":"Peter, J. et al. Gray matter atrophy pattern in elderly with subjective memory impairment. Alzheimers Dement.10, 99\u2013108 (2014).","journal-title":"Alzheimers Dement."},{"key":"69603_CR16","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1017\/S0033291711000067","volume":"41","author":"N Striepens","year":"2011","unstructured":"Striepens, N. et al. Interaction effects of subjective memory impairment and ApoE4 genotype on episodic memory and hippocampal volume. Psychol. Med.41, 1997\u20132006 (2011).","journal-title":"Psychol. Med."},{"key":"69603_CR17","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann, G. et al. Clinical diagnosis of Alzheimer\u2019s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease. Neurology34, 939\u2013944 (1984).","journal-title":"Neurology"},{"key":"69603_CR18","doi-asserted-by":"crossref","unstructured":"Petersen, R. C. et al. Mild cognitive impairment: Clinical characterization and outcome. Arch Neurol. 56, 303\u2013308 (1999).","DOI":"10.1001\/archneur.56.3.303"},{"key":"69603_CR19","volume-title":"Seoul Neuropsychological Screening Battery (SNSB)","author":"Y Kang","year":"2003","unstructured":"Kang, Y. & Na, D. L. Seoul Neuropsychological Screening Battery (SNSB) (Human Brain Research & Consulting Co., Seoul, 2003)."},{"key":"69603_CR20","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.3346\/jkms.2010.25.7.1071","volume":"25","author":"HJ Ahn","year":"2010","unstructured":"Ahn, H. J. et al. Seoul Neuropsychological Screening Battery-dementia version (SNSB-D): A useful tool for assessing and monitoring cognitive impairments in dementia patients. J. Korean Med. Sci.25, 1071\u20131076 (2010).","journal-title":"J. Korean Med. Sci."},{"key":"69603_CR21","doi-asserted-by":"publisher","first-page":"77","DOI":"10.12779\/dnd.12019.12718.12773.12777","volume":"18","author":"SH Kang","year":"2019","unstructured":"Kang, S. H. et al. The cortical neuroanatomy related to specific neuropsychological deficits in Alzheimer\u2019s Continuum. Dement Neurocogn Disord.18, 77\u201395. https:\/\/doi.org\/10.12779\/dnd.12019.12718.12773.12777 (2019) ((Epub 12019 Oct 12772)).","journal-title":"Dement Neurocogn Disord."},{"key":"69603_CR22","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1076\/jcen.21.1.127.942","volume":"21","author":"H Kim","year":"1999","unstructured":"Kim, H. & Na, D. L. Normative data on the Korean version of the Boston Naming Test. J. Clin. Exp. Neuropsychol.21, 127\u2013133 (1999).","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"69603_CR23","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3233\/JAD-2011-101611","volume":"24","author":"YJ Hong","year":"2011","unstructured":"Hong, Y. J. et al. APOE epsilon4 allele status in korean dementia patients with severe white matter hyperintensities. J. Alzheimers Dis.24, 519\u2013524. https:\/\/doi.org\/10.3233\/JAD-2011-101611 (2011).","journal-title":"J. Alzheimers Dis."},{"key":"69603_CR24","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0304-3940(99)00867-8","volume":"277","author":"KW Kim","year":"1999","unstructured":"Kim, K. W. et al. Association between apolipoprotein E polymorphism and Alzheimer\u2019s disease in Koreans. Neurosci. Lett.277, 145\u2013148 (1999).","journal-title":"Neurosci. Lett."},{"key":"69603_CR25","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.3346\/jkms.2011.26.9.1219","volume":"26","author":"HK Park","year":"2011","unstructured":"Park, H. K. et al. Clinical characteristics of a nationwide hospital-based registry of mild-to-moderate Alzheimer\u2019s disease patients in Korea: A CREDOS (Clinical Research Center for Dementia of South Korea) study. J. Korean Med. Sci.26, 1219\u20131226 (2011).","journal-title":"J. Korean Med. Sci."},{"key":"69603_CR26","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1136\/jnnp.2010.209122","volume":"82","author":"PN Wang","year":"2011","unstructured":"Wang, P. N., Hong, C. J., Lin, K. N., Liu, H. C. & Chen, W. T. APOE epsilon4 increases the risk of progression from amnestic mild cognitive impairment to Alzheimer\u2019s disease among ethnic Chinese in Taiwan. J. Neurol. Neurosurg. Psychiatry82, 165\u2013169 (2011).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"69603_CR27","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.neurobiolaging.2006.02.001","volume":"28","author":"SK Herukka","year":"2007","unstructured":"Herukka, S. K. et al. CSF Abeta42, Tau and phosphorylated Tau, APOE epsilon4 allele and MCI type in progressive MCI. Neurobiol. Aging28, 507\u2013514 (2007).","journal-title":"Neurobiol. Aging"},{"key":"69603_CR28","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1159\/000216841","volume":"27","author":"ES Blom","year":"2009","unstructured":"Blom, E. S. et al. Rapid progression from mild cognitive impairment to Alzheimer\u2019s disease in subjects with elevated levels of tau in cerebrospinal fluid and the APOE epsilon4\/epsilon4 genotype. Dement. Geriatr. Cogn. Disord.27, 458\u2013464 (2009).","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"69603_CR29","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000330492","volume":"32","author":"J Norberg","year":"2011","unstructured":"Norberg, J. et al. Regional differences in effects of APOE epsilon4 on cognitive impairment in non-demented subjects. Dement. Geriatr. Cogn. Disord.32, 135\u2013142 (2011).","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"69603_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000334607","volume":"38","author":"A Ward","year":"2012","unstructured":"Ward, A. et al. Prevalence of apolipoprotein E4 genotype and homozygotes (APOE e4\/4) among patients diagnosed with Alzheimer\u2019s disease: A systematic review and meta-analysis. Neuroepidemiology38, 1\u201317 (2012).","journal-title":"Neuroepidemiology"},{"key":"69603_CR31","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1046\/j.1469-1809.1999.6340301.x","volume":"63","author":"RM Corbo","year":"1999","unstructured":"Corbo, R. M. & Scacchi, R. Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 a \u201cthrifty\u201d allele?. Ann. Human Genet.63, 301\u2013310 (1999).","journal-title":"Ann. Human Genet."},{"key":"69603_CR32","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.jalz.2018.1002.1009","volume":"14","author":"N Mattsson","year":"2018","unstructured":"Mattsson, N. et al. Prevalence of the apolipoprotein E epsilon4 allele in amyloid beta positive subjects across the spectrum of Alzheimer\u2019s disease. Alzheimers Dement.14, 913\u2013924. https:\/\/doi.org\/10.1016\/j.jalz.2018.1002.1009 (2018) ((Epub 2018 Mar 1028)).","journal-title":"Alzheimers Dement."},{"key":"69603_CR33","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/s0022-3956(1002)00020-00021","volume":"36","author":"JA Yesavage","year":"2002","unstructured":"Yesavage, J. A. et al. Modeling the prevalence and incidence of Alzheimer\u2019s disease and mild cognitive impairment. J. Psychiatr. Res.36, 281\u2013286. https:\/\/doi.org\/10.1016\/s0022-3956(1002)00020-00021 (2002).","journal-title":"J. Psychiatr. Res."},{"key":"69603_CR34","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1212\/wnl.1251.1213.1728","volume":"51","author":"AF Jorm","year":"1998","unstructured":"Jorm, A. F. & Jolley, D. The incidence of dementia: A meta-analysis. Neurology51, 728\u2013733. https:\/\/doi.org\/10.1212\/wnl.1251.1213.1728 (1998).","journal-title":"Neurology"},{"key":"69603_CR35","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.neurobiolaging.2003.12.023","volume":"25","author":"J Raber","year":"2004","unstructured":"Raber, J., Huang, Y. & Ashford, J. W. ApoE genotype accounts for the vast majority of AD risk and AD pathology. Neurobiol. Aging25, 641\u2013650 (2004).","journal-title":"Neurobiol. Aging"},{"key":"69603_CR36","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","volume":"256","author":"RC Petersen","year":"2004","unstructured":"Petersen, R. C. Mild cognitive impairment as a diagnostic entity. J. Intern. Med.256, 183\u2013194 (2004).","journal-title":"J. Intern. Med."},{"key":"69603_CR37","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/arclin\/17.1.57","volume":"17","author":"AH Kizilbash","year":"2002","unstructured":"Kizilbash, A. H., Vanderploeg, R. D. & Curtiss, G. The effects of depression and anxiety on memory performance. Arch. Clin. Neuropsychol.17, 57\u201367 (2002).","journal-title":"Arch. Clin. Neuropsychol."},{"key":"69603_CR38","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/gps.559","volume":"17","author":"P St John","year":"2002","unstructured":"St John, P. & Montgomery, P. Are cognitively intact seniors with subjective memory loss more likely to develop dementia?. Int. J. Geriatr. Psychiatry17, 814\u2013820 (2002).","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"69603_CR39","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","volume":"278","author":"LA Farrer","year":"1997","unstructured":"Farrer, L. A. et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease\u2014a meta-analysis. J. Am. Med. Assoc.278, 1349\u20131356 (1997).","journal-title":"J. Am. Med. Assoc."},{"key":"69603_CR40","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1212\/01.wnl.0000304038.37421.cc","volume":"70","author":"S Cosentino","year":"2008","unstructured":"Cosentino, S. et al. APOE epsilon 4 allele predicts faster cognitive decline in mild Alzheimer disease. Neurology70, 1842\u20131849 (2008).","journal-title":"Neurology"},{"key":"69603_CR41","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1212\/WNL.0b013e31827f0889","volume":"80","author":"R Ossenkoppele","year":"2013","unstructured":"Ossenkoppele, R. et al. Differential effect of APOE genotype on amyloid load and glucose metabolism in AD dementia. Neurology80, 359\u2013365 (2013).","journal-title":"Neurology"},{"key":"69603_CR42","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1001\/jama.2015.4668","volume":"313","author":"WJ Jansen","year":"2015","unstructured":"Jansen, W. J. et al. Prevalence of cerebral amyloid pathology in persons without dementia: A meta-analysis. JAMA313, 1924\u20131938 (2015).","journal-title":"JAMA"},{"key":"69603_CR43","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S1474-4422(12)70191-6","volume":"11","author":"Y Stern","year":"2012","unstructured":"Stern, Y. Cognitive reserve in ageing and Alzheimer\u2019s disease. Lancet Neurol.11, 1006\u20131012 (2012).","journal-title":"Lancet Neurol."},{"key":"69603_CR44","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/j.neuropsychologia.2009.03.004","volume":"47","author":"Y Stern","year":"2009","unstructured":"Stern, Y. Cognitive reserve. Neuropsychologia47, 2015\u20132028 (2009).","journal-title":"Neuropsychologia"},{"key":"69603_CR45","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1001\/archneur.57.12.1718","volume":"57","author":"RS Wilson","year":"2000","unstructured":"Wilson, R. S. et al. Premorbid reading activity and patterns of cognitive decline in Alzheimer disease. Arch. Neurol.57, 1718\u20131723 (2000).","journal-title":"Arch. Neurol."},{"key":"69603_CR46","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1212\/WNL.53.9.1942","volume":"53","author":"Y Stern","year":"1999","unstructured":"Stern, Y., Albert, S., Tang, M. X. & Tsai, W. Y. Rate of memory decline in AD is related to education and occupation: Cognitive reserve?. Neurology53, 1942\u20131947 (1999).","journal-title":"Neurology"},{"key":"69603_CR47","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1136\/jnnp.2005.072306","volume":"77","author":"N Scarmeas","year":"2006","unstructured":"Scarmeas, N., Albert, S. M., Manly, J. J. & Stern, Y. Education and rates of cognitive decline in incident Alzheimer\u2019s disease. J. Neurol. Neurosurg. Psychiatry77, 308\u2013316 (2006).","journal-title":"J. Neurol. Neurosurg. Psychiatry"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-69603-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-69603-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-69603-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T15:31:09Z","timestamp":1670340669000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-69603-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,7]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["69603"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-69603-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,7]]},"assertion":[{"value":"6 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13365"}}